The promoter of CDH1, which encodes E-cadherin, also shows increased methylation in the inflamed mucosa of the ileum in patients with CD, which is associated with epithelial barrier dysfunction and a potentially increased risk of developing colon cancer [44]. Here, CDH1 is linked to malignant colon neoplasm.